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Abstract 
Schizophrenia is a debilitating mental disorder that affects approximately 1% of 
the world population and is associated with delusions, disorganized speech and 
behavior, hallucinations, and abnormal brain structure and function. The risk of 
developing schizophrenia is associated with both environmental and genetic risk 
factors. Schizophrenia is genetically heritable; it has been found that offspring 
have a 10% chance of inheriting the disease from an affected parent. Because 
of this genetic heritability, searches for schizophrenia genes have been long 
underway using genome-wide association studies (GWAS). One GWAS 
discovered gene is SMARCA2, a member of the SWI/SNF chromatin-
remodeling complex. Single-nucleotide polymorphisms (SNPs) in SMARCA2 
have also been associated with changes in gene expression. Koga, et al. 
associated SNPs in rs3763627 and rs3793490 with low SMARCA2 expression 
levels in the postmortem prefrontal cortex. Allelic determination of these two 
SNPs was performed for a selection of individuals with Schizophrenia and 
healthy controls using TaqMan genotyping assays. The data set was combined 
with magnetic resonance imaging (MRI) scans and calculated brain lobe 
volumes for each individual sample. It was found that the genotype GG in 
rs3793490 in affected individuals showed decreased frontal lobe gray matter 
volumes when compared to affected individuals who are T-carriers in the same 
SNP. However, this result cannot be concluded as statistically significant due to 
the small sample size of the GG group.  
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AA : 0.761 
AT : 0.228 
TT : 0.011 
Conclusion 
 
• The GG genotype in rs3793490 may be associated with decreased frontal 
   lobe gray matter volumes in individuals with schizophrenia 
 
Probands 
GG : 6  
GT : 87 
TT : 278 
484 Samples 
rs3763627 TaqMan Assay  
PRISM 7900HT/SDS 2.0 
Probands 
AA : 244 
AT : 54 
TT : 2 
566 Samples 
rs3793490 TaqMan Assay  
PRISM 7900HT/SDS 2.0 
Experimental 
Frequency 
GG : 0.016 
GT : 0.235 
TT : 0.749 
TaqMan Assay Procedure 
Illustration adapted from invitrogen.com 
Lobe Volume Determination 
• Lobe volumes were determined  
using BRAINS software developed at  
the University of Iowa  
• Brain structures are programmed into  
the software by location 
• MRI cross sections are compiled by 
the program and are used to estimate 
the total volume of the brain structure 
Frontal Lobe Gray Matter Volume in 
rs3763627 Patients and Controls 
*Measurements reported as the least squares mean in cubic centimeters 
•Statistical analysis performed using JMP 8.0.2 
Experimental 
Frequency 
AA : 0.813 
AT : 0.180 
TT : 0.007 
Controls 
AA : 140 
AT : 42 
TT : 2 
Controls 
GG : 4  
GT : 49 
TT : 142 
Experimental 
Frequency 
GG : 0.021 
GT : 0.251 
TT : 0.728 
Frontal Lobe Gray Matter Volume in 
rs3793490 Patients and Controls 
•Statistical analysis performed using JMP 8.0.2 
*Measurements reported as the least squares mean in cubic centimeters 
• Probands show a significantly 
   lower frontal lobe gray matter 
   volume than controls for the  
   genotype GG 
 
• GG probands show lower frontal  
   lobe gray matter volume than  
   probands or controls in the TG 
   and TT genotypes 
 
• Statistical relevance cannot be  
  confirmed due to small sample  
  size (GG frequency ≈ 0.017) 
Allele Frequency X2 = 1.91 
DF = 1 
p-value = 0.167 
Allele Frequency X2 = 0.349 
DF = 1 
p-value = 0.555 
• TT probands show smaller 
  frontal lobe gray matter volumes 
  than controls of the same 
  genotype 
 
• Statistical relevance cannot be 
  confirmed due to small sample 
  size (TT frequency ≈ 0) 
